Mixed neurologic and psychiatric disorders: pharmacological issues.
The number of patients with mixed neurologic and psychiatric disturbances is large. The psychiatric disturbances are often atypical in presentation and fit poorly into standard psychiatric nomenclature. They can be difficult to treat using standard psychopharmacologic approaches. This report reviews the impact of brain dysfunction on the use of conventional and nonconventional psychotropic agents in this mixed population.
McAllister
T W
TW
Section of Neuropsychiatry, Dartmouth Medical School, Concord, NH 03301-3861.
D001925:Brain Damage, Chronic / Q000150:complications* / Q000188:drug therapy / Q000523:psychology; D003131:Combined Modality Therapy; D006801:Humans; D001523:Mental Disorders / Q000150:complications* / Q000188:drug therapy / Q000523:psychology; D019965:Neurocognitive Disorders / Q000150:complications* / Q000188:drug therapy / Q000523:psychology; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*
D011619:Psychotropic Drugs